PO Perche, MK Cook… - Annals of …, 2023 - journals.sagepub.com
Objective The objective of this article is to review abrocitinib, an oral Janus kinase (JAK) 1 inhibitor, for the treatment of patients with moderate-to-severe atopic dermatitis (AD). Data …
S Zhou, F Qi, Y Gong, J Zhang, B Zhu - Dermatology, 2021 - karger.com
Background: Atopic dermatitis (AD) is a widely acquired, relapsing inflammatory skin disease. Biologics are now widely used in patients with moderate-to-severe AD. Objective …
P Xu, P Shen, B Yu, X Xu, R Ge, X Cheng… - European Journal of …, 2020 - Elsevier
Abstract The Janus kinases or JAKs are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the …
SL Said-Fernandez… - Experimental and …, 2021 - spandidos-publications.com
Vitiligo is a skin disorder characterized by depigmentation of the skin due to a lack of melanin. This condition affects men and woman of all ages and its incidence is not restricted …
Janus kinases (JAKs) are a group of intracytoplasmic tyrosine kinase proteins that bind to the cytoplasmic part of the transmembrane cytokine receptors and regulate signaling. The …
CE Jo, M Gooderham, J Beecker - International Journal of …, 2022 - Wiley Online Library
Increasing understanding of cytokines as major drivers of immune‐mediated diseases has revolutionized targeted treatments for these conditions. As the pathogenesis of autoimmune …
E Petrova, A Hovnanian - Expert Opinion on Orphan Drugs, 2020 - Taylor & Francis
Introduction: Netherton syndrome (NS) is a rare and severe ichthyosis characterized by superficial scaling, skin inflammation, a specific hair shaft defect, severe atopic …
Y Jiang, L Rubin, Z Zhou, H Zhang, Q Su… - Cytokine & Growth …, 2022 - Elsevier
The development of therapies for SARS-CoV-2 infection, based on virus biology and pathology, and of large-and small-scale randomized controlled trials, have brought forward …